Veru Inc. Files 8-K on Financials

Ticker: VERU · Form: 8-K · Filed: May 8, 2025 · CIK: 863894

Sentiment: neutral

Topics: financial-reporting, 8-k, company-update

TL;DR

VERU filed an 8-K today covering financials. Check it out.

AI Summary

Veru Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhibits. The company, formerly known as Female Health Co. and Wisconsin Pharmacal Company Inc., is incorporated in Wisconsin and headquartered in Miami, Florida.

Why It Matters

This filing provides investors with crucial updates on Veru Inc.'s financial performance and condition, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Numbers

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

The 8-K indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K filing submitted?

The filing was submitted on May 8, 2025.

What is Veru Inc.'s principal executive office address?

The principal executive offices are located at 2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127.

Has Veru Inc. operated under different names previously?

Yes, Veru Inc. was formerly known as Female Health Co. and Wisconsin Pharmacal Company Inc.

What is the company's state of incorporation?

Veru Inc. is incorporated in Wisconsin.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding VERU INC. (VERU).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing